123
Views
245
CrossRef citations to date
0
Altmetric
Cell Growth and Development

CREB Binding Protein Interacts with Nucleoporin-Specific FG Repeats That Activate Transcription and Mediate NUP98-HOXA9 Oncogenicity

, , , , &
Pages 764-776 | Received 14 Aug 1998, Accepted 29 Sep 1998, Published online: 28 Mar 2023

REFERENCES

  • Adler, H. T., F. S. Nallaseth, G. Walter, and J. Tkachuk 1997. HRX leukemic fusion proteins form a heterocomplex with the leukemia-associated protein SET and protein phosphatase 2A. J. Biol. Chem. 272:28407–28414.
  • Arai, Y., F. Hosoda, H. Kobayashi, K. Arai, Y. Hayashi, N. Kamada, Y. Kaneko, and J. Ohki 1997. The inv(11)(p15q22) chromosome translocation of de novo and therapy-related myeloid malignancies results in fusion of the nucleoporin gene, NUP98, with the putative RNA helicase gene, DDX10. Blood 89:3936–3944.
  • Bastos, R., A. Lin, M. Enarson, and J. Burke 1996. Targeting and function in mRNA export of nuclear pore complex protein Nup153. J. Cell Biol. 134:1141–1156.
  • Bedigian, H. G., D. A. Johnson, N. A. Jenkins, N. G. Copeland, and J. Evans 1984. Spontaneous and induced leukemias of myeloid origin in recombinant inbred BXH mice. J. Virol. 51:586–594.
  • Bedigian, H. G., B. A. Taylor, and J. Meier 1981. Expression of murine leukemia viruses in the highly lymphomatous BXH-2 recombinant inbred mouse strain. J. Virol. 39:632–640.
  • Benson, G. V., T. H. Nguyen, and J. Maas 1995. The expression pattern of the murine Hoxa-10 gene and the sequence recognition of its homeodomain reveal specific properties of Abdominal B-like genes. Mol. Cell. Biol. 15:1591–1601.
  • Borrow, J., A. M. Shearman, V. P. Stanton Jr., R. Becher, T. Collins, A. J. Williams, I. Dube, F. Katz, Y. L. Kwong, C. Morris, K. Ohyashiki, K. Toyama, J. Rowley, and J. Housman 1996. The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9. Nat. Genet. 12:159–167.
  • Borrow, J., V. P. Stanton Jr., J. M. Andresen, R. Becher, F. G. Behm, R. S. Chaganti, C. I. Civin, C. Disteche, I. Dube, A. M. Frischauf, D. Horsman, F. Mitelman, S. Volinia, A. E. Watmore, and J. Housman 1996. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat. Genet. 14:33–41.
  • Brindle, P., and J. van Deursen. Unpublished data.
  • Chan, S. K., L. Jaffe, M. Capovilla, J. Botas, and J. Mann 1994. The DNA binding specificity of Ultrabithorax is modulated by cooperative interactions with extradenticle, another homeoprotein. Cell 78:603–615.
  • Chang, C. P., L. Brocchieri, W. F. Shen, C. Largman, and J. Cleary 1996. Pbx modulation of Hox homeodomain amino-terminal arms establishes different DNA-binding specificities across the Hox locus. Mol. Cell. Biol. 16:1734–1745.
  • Chang, C. P., W. F. Shen, S. Rozenfeld, H. J. Lawrence, C. Largman, and J. Cleary 1995. Pbx proteins display hexapeptide-dependent cooperative DNA binding with a subset of Hox proteins. Genes Dev. 9:663–674.
  • Dalrymple, M. A., D. J. McGeoch, A. J. Davison, and J. Preston 1985. DNA sequence of the herpes simplex virus type 1 gene whose product is responsible for transcriptional activation of immediate early promoters. Nucleic Acids Res. 13:7865–7879.
  • Fornerod, M., J. Boer, S. van Baal, M. Jaegle, M. von Lindern, K. G. Murti, D. Davis, J. Bonten, A. Buijs, and J. Grosveld 1995. Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements. Oncogene 10:1739–1748.
  • Fu, G. K., G. Grosveld, and J. Markovitz 1997. DEK, an autoantigen involved in a chromosomal translocation in acute myelogenous leukemia, binds to the HIV-2 enhancer. Proc. Natl. Acad. Sci. USA 94:1811–1815.
  • Fukuda, M., Y. Gotoh, and J. Nishida 1997. Interaction of MAP kinase with MAP kinase kinase: its possible role in the control of nucleocytoplasmic transport of MAP kinase. EMBO J. 16:1901–1908.
  • Gossen, M., and J. Bujard 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547–5551.
  • Hirai, H., M. F. Roussel, J. Y. Kato, R. A. Ashmun, and J. Sherr 1995. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15:2672–2681.
  • Huang, S. Y., J. L. Tang, Y. J. Liang, C. H. Wang, Y. C. Chen, and J. Tien 1997. Clinical, haematological and molecular studies in patients with chromosome translocation t(7;11): a study of four Chinese patients in Taiwan. Br. J. Haematol. 96:682–687.
  • Ida, K., I. Kitabayashi, T. Taki, M. Taniwaki, K. Noro, M. Yamamoto, M. Ohki, and J. Hayashi 1997. Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13). Blood 90:4699–4704.
  • Janknecht, R., and J. Hunter 1996. Transcription. A growing coactivator network. Nature 383:22–23.
  • Kitabayashi, I., K. Ida, F. Morohoshi, A. Yokoyama, N. Mitsuhashi, K. Shimizu, N. Nomura, Y. Hayashi, and J. Ohki 1998. The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8(ETO/CDR) family, MTGR1. Mol. Cell. Biol. 18:846–858.
  • Kraemer, D., R. W. Wozniak, G. Blobel, and J. Radu 1994. The human CAN protein, a putative oncogene product associated with myeloid leukemogenesis, is a nuclear pore complex protein that faces the cytoplasm. Proc. Natl. Acad. Sci. USA 91:1519–1523.
  • Kroon, E., J. Krosl, U. Thorsteinsdottir, S. Baban, A. M. Buchberg, and J. Sauvageau 1998. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J. 17:3714–3725.
  • Lavau, C., S. J. Szilvassy, R. Slany, and J. Cleary 1997. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J. 16:4226–4237.
  • Lawrence, H. J., C. D. Helgason, G. Sauvageau, S. Fong, D. J. Izon, R. K. Humphries, and J. Largman 1997. Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood 89:1922–1930.
  • Lu, Q., and J. Kamps 1997. Heterodimerization of Hox proteins with Pbx1 and oncoprotein E2a-Pbx1 generates unique DNA-binding specificities at nucleotides predicted to contact the N-terminal arm of the Hox homeodomain—demonstration of Hox-dependent targeting of E2a-Pbx1 in vivo. Oncogene 14:75–83.
  • Martin, K. J., J. W. Lillie, and J. Green 1990. Evidence for interaction of different eukaryotic transcriptional activators with distinct cellular targets. Nature 346:147–152.
  • Moriggl, R., S. Berchtold, K. Friedrich, G. J. Standke, W. Kammer, M. Heim, M. Wissler, E. Stocklin, F. Gouilleux, and J. Groner 1997. Comparison of the transactivation domains of Stat5 and Stat6 in lymphoid cells and mammary epithelial cells. Mol. Cell. Biol. 17:3663–3678.
  • Moskow, J. J., F. Bullrich, K. Huebner, I. O. Daar, and J. Buchberg 1995. Meis1, a PBX1-related homeobox gene involved in myeloid leukemia in BXH-2 mice. Mol. Cell. Biol. 15:5434–5443.
  • Muller, A. J., J. C. Young, A. M. Pendergast, M. Pondel, N. R. Landau, D. R. Littman, and J. Witte 1991. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol. Cell. Biol. 11:1785–1792.
  • Nagata, K., H. Kawase, H. Handa, K. Yano, M. Yamasaki, Y. Ishimi, A. Okuda, A. Kikuchi, and J. Matsumoto 1995. Replication factor encoded by a putative oncogene, set, associated with myeloid leukemogenesis. Proc. Natl. Acad. Sci. USA 92:4279–4283.
  • Nakajima, T., C. Uchida, S. F. Anderson, C. G. Lee, J. Hurwitz, J. D. Parvin, and J. Montminy 1997. RNA helicase A mediates association of CBP with RNA polymerase II. Cell 90:1107–1112.
  • Nakamura, T., D. A. Largaespada, M. P. Lee, L. A. Johnson, K. Ohyashiki, K. Toyama, S. J. Chen, C. L. Willman, I. M. Chen, A. P. Feinberg, N. A. Jenkins, N. G. Copeland, J. D. Shaughnessy Jr.. 1996. Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nat. Genet. 12:154–158.
  • Nakamura, T., D. A. Largaespada, J. D. Shaughnessy Jr., N. A. Jenkins, and J. Copeland 1996. Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias. Nat. Genet. 12:149–153.
  • Nigg, E. A. 1997. Nucleocytoplasmic transport: signals, mechanisms and regulation. Nature 386:779–787.
  • Ohno, M., M. Fornerod, and J. Mattaj 1998. Nucleocytoplasmic transport: the last 200 nanometers. Cell 92:327–336.
  • Phelan, M. L., I. Rambaldi, and J. Featherstone 1995. Cooperative interactions between HOX and PBX proteins mediated by a conserved peptide motif. Mol. Cell. Biol. 15:3989–3997.
  • Popperl, H., M. Bienz, M. Studer, S. K. Chan, S. Aparicio, S. Brenner, R. S. Mann, and J. Krumlauf 1995. Segmental expression of Hoxb-1 is controlled by a highly conserved autoregulatory loop dependent upon exd/pbx. Cell 81:1031–1042.
  • Radu, A., M. S. Moore, and J. Blobel 1995. The peptide repeat domain of nucleoporin Nup98 functions as a docking site in transport across the nuclear pore complex. Cell 81:215–222.
  • Rauskolb, C., and J. Wieschaus 1994. Coordinate regulation of downstream genes by extradenticle and the homeotic selector proteins. EMBO J. 13:3561–3569.
  • Rowley, J. D., S. Reshmi, O. Sobulo, T. Musvee, J. Anastasi, S. Raimondi, N. R. Schneider, J. C. Barredo, E. S. Cantu, B. Schlegelberger, F. Behm, N. A. Doggett, J. Borrow, and J. Zeleznik-Le 1997. All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders. Blood 90:535–541.
  • Sauvageau, G., P. M. Lansdorp, C. J. Eaves, D. E. Hogge, W. H. Dragowska, D. S. Reid, C. Largman, H. J. Lawrence, and J. Humphries 1994. Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. Proc. Natl. Acad. Sci. USA 91:12223–12227.
  • Schnabel, C. A., and J. Abate-Shen 1996. Repression by HoxA7 is mediated by the homeodomain and the modulatory action of its N-terminal-arm residues. Mol. Cell. Biol. 16:2678–2688.
  • Shen, W. F., J. C. Montgomery, S. Rozenfeld, J. J. Moskow, H. J. Lawrence, A. M. Buchberg, and J. Largman 1997. AbdB-like Hox proteins stabilize DNA binding by the Meis1 homeodomain proteins. Mol. Cell. Biol. 17:6448–6458.
  • Shen, W. F., S. Rozenfeld, H. J. Lawrence, and J. Largman 1997. The Abd-B-like Hox homeodomain proteins can be subdivided by the ability to form complexes with Pbx1a on a novel DNA target. J. Biol. Chem. 272:8198–8206.
  • Taki, T., M. Sako, M. Tsuchida, and J. Hayashi 1997. The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene. Blood 89:3945–3950.
  • van Dijk, M. A., and J. Murre 1994. Extradenticle raises the DNA binding specificity of homeotic selector gene products. Cell 78:617–624.
  • van Dijk, M. A., L. T. Peltenburg, and J. Murre 1995. Hox gene products modulate the DNA binding activity of Pbx1 and Pbx2. Mech. Dev. 52:99–108.
  • von Lindern, M., M. Fornerod, N. Soekarman, S. van Baal, M. Jaegle, A. Hagemeijer, D. Bootsma, and J. Grosveld 1992. Translocation t(6;9) in acute nonlymphocytic leukaemia results in the formation of a DEK-CAN fusion gene. Baillieres Clin. Haematol. 5:857–879.
  • von Lindern, M., S. van Baal, J. Wiegant, A. Raap, A. Hagemeijer, and J. Grosveld 1992. Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3′ half to different genes: characterization of the set gene. Mol. Cell. Biol. 12:3346–3355.
  • Wilson, I. A., H. L. Niman, R. A. Houghten, A. R. Cherenson, M. L. Connolly, and J. Lerner 1984. The structure of an antigenic determinant in a protein. Cell 37:767–778.
  • Yang, C., L. H. Shapiro, M. Rivera, A. Kumar, and J. Brindle 1998. A role for CREB binding protein and p300 transcriptional coactivators in Ets-1 transactivation functions. Mol. Cell. Biol. 18:2218–2229.
  • Yu, B. D., J. L. Hess, S. E. Horning, G. A. Brown, and J. Korsmeyer 1995. Altered Hox expression and segmental identity in Mll-mutant mice. Nature 378:505–508.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.